Related Experiment Video
Updated: Feb 1, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Transcriptomic data for analyzing global gene expression patterns in Methicillin-resistance Staphylococcus aureus in
Shrikant Pawar1,2, Xiangyu Yao3, ChungDar Lu4
1Department of Biology, Georgia State University, 33 Gilmer Street SE, 30303 Atlanta, GA, USA.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is a rapidly emerging bacteria causing infection, which has developed resistance to most of the beta-lactam antibiotics because of newly acquired low-affinity penicillin binding protein (PBP2a), which can continue to build the cell wall when other PBPs are blocked by beta-lactams. Exogenous spermine exerts a dose dependent inhibition effect on the growth of E. coli, Salmonella enterica serovar and Staphylococcus aureus. We have selected an MRSA Mu50 derivative which harbors mutation on PBP2 gene (named as MuM) showing spermine resistance and which confers a complete abolishment of spermine-beta-lactam synergy. A transcriptomic profiling of MuM against Mu50 (wild type) without any treatment, MuM and Mu50 in response to high dose spermine and Mu50 in response to spermine-beta-lactam synergy is provided in this article. These comparisons will enhance our current understanding of mechanisms of spermine-beta-lactam synergy sensitization effects on MRSA.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) resistance to antibiotics can be altered by spermine. A specific MRSA mutation abolishes spermine-beta-lactam synergy, offering new insights into bacterial resistance mechanisms.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen resistant to beta-lactam antibiotics due to altered penicillin-binding protein (PBP2a).
- Exogenous spermine has demonstrated dose-dependent inhibitory effects on the growth of various bacteria, including Staphylococcus aureus.
Purpose of the Study:
- To investigate the impact of a PBP2 gene mutation on spermine resistance and spermine-beta-lactam synergy in MRSA.
- To elucidate the molecular mechanisms underlying spermine-beta-lactam synergy sensitization in MRSA through transcriptomic analysis.
Main Methods:
- Selection of an MRSA Mu50 derivative (MuM) with a PBP2 gene mutation conferring spermine resistance.
- Transcriptomic profiling comparing MuM and wild-type Mu50 under various conditions: no treatment, high-dose spermine exposure, and combined spermine-beta-lactam treatment.
Main Results:
- The PBP2 mutation in MuM resulted in spermine resistance and abolished the synergistic effect of spermine and beta-lactams.
- Transcriptomic data provided insights into the differential gene expression patterns in response to spermine and beta-lactam treatments in wild-type and mutant MRSA strains.
Conclusions:
- The PBP2 gene mutation significantly alters MRSA's response to spermine and beta-lactam antibiotics.
- Understanding these mechanisms can inform the development of novel therapeutic strategies against MRSA infections.
More Related Videos
Related Concept Videos
Responses to Salt Stress
Responses to Heat and Cold Stress
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
What is Gene Expression?
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Cell Specific Gene Expression

